Generic · Tablet · Updated Nov 11, 2026
Propafenone 300 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for propafenone 300 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Propafenone 300 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $11.10
- 52-week low
- $11.10
- 52-week high
- $15.88
- A year ago
- $14.55
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $0.3880 | $0.3699 | -4.7% | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $0.4247 | $0.3880 | -8.6% | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $0.4635 | $0.4247 | -8.4% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $0.4781 | $0.4635 | -3.1% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $0.4409 | $0.4781 | +8.5% | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $0.4229 | $0.4409 | +4.2% | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $0.3955 | $0.4229 | +6.9% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $0.4157 | $0.3955 | -4.9% | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for propafenone 300 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
4 companies sell propafenone 300 mg tablet under 8 package codes (NDCs). Pharmacies pay the same per tablet whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 62559-232-01 | $0.3699 |
| Aurobindo Pharma Limited | 59651-258-01 | $0.3699 |
| Strides Pharma Science Limited | 64380-163-01 64380-246-01 | $0.3699 |
| Bryant Ranch Prepack | 63629-1989-1 63629-9280-1 72162-1753-1 +1 more | - |
All 8 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Would 150 mg tablet work for me instead?" Pharmacies pay $0.1174 per tablet for it, against $0.3699 for this one. Only your prescriber can say whether a different strength or form suits you.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other propafenone strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 225 mg (12 hr) extended-release capsule | $0.2624 | $7.87 / 30 capsules |
| 325 mg (12 hr) extended-release capsule | $0.6121 | $18.36 / 30 capsules |
| 425 mg (12 hr) extended-release capsule | $0.6045 | $18.14 / 30 capsules |
| 150 mg tablet | $0.1174 | $3.52 / 30 tablets |
| 225 mg tablet | $0.2092 | $6.27 / 30 tablets |
Official label & what changed
These highlights do not include all the information needed to use PROPAFENONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PROPAFENONE HYDROCHLORIDE TABLETS.PROPAFENONE HYDROCHLORIDE tablets, for oral useInitial U.S. Approval: 1989
WARNING: MORTALITY
In the National Heart, Lung, and Blood Institute's Cardiac Arrhythmia Suppression Trial (CAST), a long-term, multicenter, randomized, double-blind trial in subjects with asymptomatic non-life-threatening ventricular arrhythmias who had a myocardial infarction more than 6 days but less than 2 years previously, an increased rate of death or reversed cardiac arrest rate (7.7%; 56/730) was seen in subjects treated with encainide or flecainide (Class IC antiarrhythmics) compared with that seen in subjects assigned to placebo (3.0%; 22/725). The average duration of treatment with encainide or flecainide in this trial was 10 months.
The applicability of the CAST results to other populations (e.g., those without recent myocardial infarction) or other antiarrhythmic drugs is uncertain, but at present, it is prudent to consider any IC antiarrhythmic to have a significant proarrhythmic risk in patients with structural heart disease. Given the lack of any evidence that these drugs improve survival, antiarrhythmic agents should generally be avoided in patients with non-life-threatening ventricular arrhythmias, even if the patients are experiencing unpleasant, but not life-threatening, symptoms or signs.
WARNING: MORTALITY
|
See full prescribing information for complete boxed warning.
• An increased rate of death or reversed cardiac arrest rate was seen in subjects treated with encainide or flecainide (Class IC antiarrhythmics) compared with that seen in subjects assigned to placebo. At present, it is prudent to consider any IC antiarrhythmic to have a significant risk of provoking proarrhythmic events in patients with structural heart disease.
• Given the lack of any evidence that these drugs improve survival, antiarrhythmic agents should generally be avoided in patients with non-life-threatening ventricular arrhythmias, even if the patients are experiencing unpleasant, but not life-threatening, symptoms or signs.
|
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about propafenone 300 mg tablet
How much does propafenone 300 mg tablet cost without insurance?
Pharmacies pay about $11.10 for 30 tablets ($0.3699 per tablet) as of November 11, 2026. A fair cash price is about $23.26: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $22.76 including shipping.
Is my price for propafenone 300 mg tablet fair?
Compare it with the fair cash price of $23.26 for 30 tablets. Up to about $29.08 is fair; above $46.52 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is propafenone 300 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay fell 4.7%. Over a year it fell 23.8%. See the 52-week chart.
Who makes propafenone 300 mg tablet?
4 companies: ANI Pharmaceuticals, Inc., Aurobindo Pharma Limited, Strides Pharma Science Limited, Bryant Ranch Prepack. See every package code.
Is propafenone in shortage?
No shortage is reported right now. We check every day.
Has propafenone been recalled?
6 recalls on record, 4 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about propafenone 300 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.